Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

News in Depth

Circular DNA Throws Gene Regulation for a Loop

DOI: 10.1158/2159-8290.CD-ND2019-016 Published February 2020
  • Article
  • Info & Metrics
  • PDF
Loading

Circular tracks of DNA found inside cancer cells commonly contain large numbers of replicate oncogenes, and the uneven inheritance pattern of this DNA, located outside of chromosomes, enables tumor cells to rapidly adapt to selective pressures such as chemotherapy. However, the impact of this so-called extrachromosomal DNA (ecDNA) goes beyond genomic amplifications, regulatory flexibility, and accelerated tumor evolution.

Two new studies reveal how the topology of ecDNA affects gene regulation to promote cancer growth. A third report details how ecDNA can reintegrate itself into chromosomes, disrupting cancer-related genes. And a preprint article demonstrates the broad clinical relevance of the phenomenon by linking ecDNA-based amplifications to shorter survival times across a range of tumor types.

The findings collectively fill in key details about how oncogene-containing ecDNA boosts tumor aggressiveness and fuels resistance to therapies—insights that have helped jump-start at least one new company, Boundless Bio. The company, which launched in September 2019, is focused on “understanding and finding the vulnerabilities that are created by having this really different kind of DNA,” says cofounder Paul Mischel, MD, of the University of California, San Diego (UCSD).

With the growing appreciation of ecDNA's critical role in cancer development, Mischel adds, “I think we're at the dawning of a new field.” Late in January, researchers gathered in Berlin, Germany, for the first-ever meeting dedicated to circular DNA's role in disease and normal development.

Scientists first noticed ecDNA under the microscope more than a half-century ago, but it was only in the past 5 years or so that the research community began to appreciate the contribution of these loops to cancer cell behavior. A study from Mischel and UCSD's Vineet Bafna, PhD, also a Boundless Bio cofounder, demonstrated that ecDNA amplifications can rapidly increase oncogene copy number and accelerate intratumor heterogeneity, enabling cancers to adapt more effectively to variable environmental conditions (Nature 2017;543:122–5). Yet questions loomed about how the structure and spatial architecture of ecDNA contributed to pathogenesis.

In their recent study, Mischel and Bafna—along with their UCSD colleague Bing Ren, PhD, and Howard Chang, MD, PhD, another Boundless Bio cofounder from Stanford University School of Medicine in California—showed that the genomic packaging of ecDNA in several tumor types is unlike that of normal chromosomes (Nature 2019;575:699–703). Although ecDNA is wound into condensed complexes, it is not as compact as typical chromatin.

This structure makes the encoded genes more accessible for active transcription, which, along with the increased copy number, helps explain why oncogenes encoded on ecDNA are among the most highly expressed genes in tumors. The circularity of ecDNA also creates more long-distance interactions within the active chromatin that could further promote oncogene expression. “The shape is actually changing the regulation of the genes,” Mischel says.

In a separate report, another team discovered that noncoding enhancer elements are frequently coamplified alongside oncogenes on ecDNA (Cell 2019;179:1330–41). In glioblastomas with EGFR amplifications, the researchers showed, having the additional regulatory elements brought about a molecular rewiring of gene regulation, with the many enhancers combining forces to bolster oncogene expression.

“These amplifications are scooping up as many regulatory elements as they can get their hands on,” says Peter Scacheri, PhD, of Case Western Reserve University in Cleveland, OH, “and the vast majority of [the enhancers], if not all of them, are providing some proliferative advantage to the cancer cells.” Scacheri co-led the study with UCSD's Jeremy Rich, MD.

A third paper from Anton Henssen, MD, PhD, of Charité University Hospital Berlin in Germany, and Richard Koche, PhD, of Memorial Sloan Kettering Cancer Center in New York, NY, explored the impact of ecDNA slipping back into chromosomes in neuroblastomas (Nat Genet 2020;52:29–34). In these pediatric brain cancers, genomic reintegration of ecDNA into tumor-suppressor genes and nearby proto-oncogenes caused their inactivation and activation, respectively. As a result, patients with ecDNA-derived rearrangements had worse clinical outcomes than patients without such rearrangements.

“It's a striking clinical finding,” Henssen says. “These circular DNAs serve as substrates for further oncogenic genome remodeling.”

Additional support for the idea that ecDNA-based amplification events result in increased tumor aggressiveness and less favorable patient prognoses comes from a manuscript posted to the preprint server bioRxiv by Mischel, Bafna, and their fellow Boundless Bio cofounder Roel Verhaak, PhD, of The Jackson Laboratory for Genomic Medicine in Farmington, CT (bioRxiv 2019 Nov 28). By looking at whole-genome sequencing data from nearly 2,000 tumor samples, the researchers showed that amplified ecDNA occurred in at least 26% of cancers analyzed—and across a wide variety of histologies to boot.

What's more, patients whose tumors harbored ecDNA had worse outcomes than patients whose tumors had either noncircular amplifications or no amplifications at all. Yet perhaps the same genetic trick that gives these intractable cancers their selective edge will ultimately lead to the tumors' demise, Mischel says. At Boundless Bio, he and his colleagues now hope to therapeutically exploit any vulnerability created by hosting ecDNA in the cell.

It is “not an unreasonable premise,” says Anindya Dutta, MD, PhD, a molecular biologist at the University of Virginia School of Medicine in Charlottesville, who is unaffiliated with the company. “Clearing out the circles may be a possibility for therapy.” –Elie Dolgin

Notes

For more news on cancer research, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/CDNews.

  • ©2020 American Association for Cancer Research.
View Abstract
PreviousNext
Back to top
Cancer Discovery: 10 (2)
February 2020
Volume 10, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Circular DNA Throws Gene Regulation for a Loop
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Circular DNA Throws Gene Regulation for a Loop
Cancer Discov February 1 2020 (10) (2) 170; DOI: 10.1158/2159-8290.CD-ND2019-016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Circular DNA Throws Gene Regulation for a Loop
Cancer Discov February 1 2020 (10) (2) 170; DOI: 10.1158/2159-8290.CD-ND2019-016
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • What Biden's Presidency Will Mean for Cancer Research
  • Immunotherapy a Likely New Standard for GI Cancers
  • Cancer Immunotherapies Helped Shape COVID Vaccines
Show more News in Depth
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement